Cas medical systems inc (CASM)
Income statement / TTM
Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Net sales from continuing operations

-

21,239

20,383

19,664

-

17,250

17,684

17,761

18,674

20,375

20,362

20,421

19,486

17,107

16,889

18,024

19,214

22,228

22,851

22,051

21,915

21,922

22,680

22,836

22,669

22,022

21,697

22,216

22,450

22,947

23,480

0

0

0

Cost of sales

-

9,077

8,718

8,801

-

7,380

7,803

7,661

8,175

9,425

9,589

9,835

9,516

8,235

8,383

9,544

10,656

13,364

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

-

-

-

-

-

-

-

-

Asset impairment charge

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Cost of sales

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

13,565

13,187

13,181

13,757

13,892

14,097

14,092

0

0

0

Gross profit

12,706

12,161

11,665

10,862

10,258

9,870

9,881

10,100

10,498

10,950

10,773

10,585

9,970

8,871

8,505

8,479

8,558

8,813

8,134

7,668

7,550

7,947

9,029

9,293

9,103

8,834

8,515

8,458

8,557

8,849

9,387

0

0

0

Operating expenses:
Research and development

3,181

3,133

3,224

3,249

3,234

3,133

3,143

3,103

3,272

3,518

3,556

3,636

3,514

3,306

3,304

3,267

3,316

3,710

3,873

4,040

4,211

4,368

4,262

4,182

4,019

3,757

3,847

3,702

3,525

2,990

2,459

0

0

0

Selling, general and administrative

14,015

13,515

13,245

13,275

13,418

13,728

13,788

13,776

13,569

13,713

13,751

13,581

13,097

11,895

11,395

11,613

11,956

13,448

14,016

13,936

13,792

13,232

13,066

12,502

12,528

11,937

11,845

11,926

11,509

11,459

11,004

0

0

0

Total operating expenses

17,197

16,648

16,469

16,524

16,652

16,861

16,931

16,880

16,842

17,232

17,308

17,217

16,611

15,201

14,699

14,881

15,273

17,159

17,889

17,977

18,003

17,601

17,329

16,685

16,548

15,694

15,692

15,629

15,034

14,450

13,463

0

0

0

Operating loss

-4,491

-4,487

-4,804

-5,661

-6,394

-6,991

-7,050

-6,780

-6,343

-6,282

-6,534

-6,632

-6,641

-6,330

-6,193

-6,402

-6,714

-8,346

-9,755

-10,308

-10,453

-9,654

-8,299

-7,391

-7,444

-6,860

-7,177

-7,170

-6,476

-5,600

-4,076

0

0

0

Interest expense, net

1,469

1,445

1,412

1,088

1,076

1,061

1,051

1,108

1,048

996

948

840

859

868

878

919

786

653

514

335

316

296

255

179

113

0

0

0

-

-

-

-

-

-

Other income

-

-

-

-

-

-

-

-

42

36

10

9

4

1

18

17

18

18

4

20

407

410

410

410

39

49

53

40

26

3

-28

0

0

0

Loss from continuing operations before income taxes

-5,961

-5,932

-6,217

-6,750

-7,470

-8,044

-8,065

-7,850

-7,349

-7,241

-7,472

-7,463

-7,496

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from continuing operations before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,450

-5,596

-4,104

0

0

0

Income tax benefit

-

37

-1,592

-1,642

-1,745

-1,927

-381

-435

-1,424

-1,346

-1,329

-1,241

-209

0

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-124

-247

-402

0

0

0

Loss from continuing operations

-5,961

-5,970

-4,624

-5,108

-5,725

-6,116

-7,683

-7,414

-5,925

-9,116

-9,363

-9,443

-7,287

-3,828

0

0

-

0

-

-

-

-

-

-

-

-

-

-

-6,325

-5,348

-3,701

0

0

0

Discontinued operations:
Income from discontinued operations

-

40

308

450

745

1,269

1,242

1,396

1,277

928

881

646

621

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of discontinued operations

-

0

-

-

-

0

-

-

2,911

2,917

2,917

2,917

-24

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income tax expense

-

-37

1,592

1,642

1,745

1,927

381

435

1,424

1,346

1,329

1,241

209

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income from discontinued operations

-

77

3,104

3,196

3,388

3,699

828

929

2,764

2,500

2,469

2,322

388

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

242

439

654

0

0

0

Loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-5,961

-5,892

-1,520

-1,911

-2,337

-2,417

-6,854

-6,485

-3,161

-3,395

-3,673

-3,899

-6,898

-6,899

-6,959

-7,270

-7,601

-8,991

-10,264

-10,624

-10,362

-9,329

-7,933

-6,949

-7,308

-6,842

-7,132

-6,823

-6,083

-4,909

-3,046

0

0

0

Preferred stock dividend accretion

1,703

1,674

1,645

1,616

1,589

1,561

1,534

1,508

1,482

1,457

1,432

1,407

1,383

1,359

1,336

1,313

1,290

1,268

1,246

1,225

1,203

1,183

1,162

1,142

1,123

1,123

914

0

-

0

0

-

-

-

Net loss applicable to common stockholders

-7,664

-7,566

-3,166

-3,528

-3,926

-3,978

-8,389

-7,994

-4,643

-4,852

-5,105

-5,306

-8,281

-8,258

-8,295

-8,583

-8,892

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss applicable to common stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-5,271

-3,120

0

0

0

Loss per common share from continuing operations - basic and diluted

-0.07

-0.06

-0.08

-0.07

-0.08

-0.01

-0.09

-0.09

-0.09

-0.07

-0.09

-0.03

-0.08

-0.08

-0.09

-0.09

-

-0.10

-

-

-

-0.19

-0.22

-0.14

-

-0.14

-0.15

-0.17

-0.15

-0.16

-0.12

-0.10

-0.06

-0.02

Income per common share from discontinued operations: basic and diluted

-

0.00

0.00

0.00

0.01

0.11

0.00

0.01

0.02

0.01

0.01

0.07

0.00

0.01

0.00

0.01

-

0.00

-

-

-

-

-

-

-

-

-

-

0.00

0.00

0.01

0.01

0.02

0.02

Per share basic and diluted loss applicable to common stockholders

-0.07

-0.06

-0.08

-0.07

-0.07

0.10

-0.09

-0.08

-0.07

-0.06

-0.08

0.04

-0.08

-0.07

-0.09

-0.08

-0.12

-0.10

-0.13

-0.11

-

-

-

-

-

-

-

-

-0.15

-0.16

-0.11

-0.09

-0.04

0.00

Weighted-average number of common shares outstanding: Basic and diluted

27,883

27,833

27,750

27,611

27,351

27,335

27,329

27,025

26,849

26,833

26,823

26,800

26,760

26,643

26,595

22,804

19,280

19,283

19,226

19,148

18,798

17,471

13,425

13,391

13,353

13,313

13,260

13,218

13,174

13,144

13,086

13,011

12,808

11,617